E
Element Biosciences
A company focused on the development of genetic analysis tools
About Element Biosciences
Element Biosciences is a biotechnology startup that specializes in next-generation sequencing (NGS) technology. The company's primary product is the AVITI System, a compact benchtop design that offers high-quality sequencing at a low cost. This system is designed to meet the needs of end users by delivering industry-leading accuracy at low run costs, enabling users to do more with their resources.
Read full description
Element Biosciences operates in the biotechnology market, serving clients in various fields that require DNA sequencing. These clients could range from academic researchers to pharmaceutical companies. The company's business model revolves around the sale of its AVITI System and the provision of sequencing services. The AVITI System is designed to be cost-effective, charging only $1 per million reads, which is significantly lower than the industry average.
The company has also established partnerships with other firms in the biotech industry, such as QIAGEN, to offer complete NGS workflows for the AVITI System. This partnership allows Element Biosciences to provide a comprehensive solution for its clients' sequencing needs.
Element Biosciences also offers a grant program, the 2023 AVITI for All Grant, which provides free sequencing for any application in any field. This initiative not only accelerates research but also showcases the capabilities of the AVITI System.
In summary, Element Biosciences is a biotech startup that offers affordable and high-quality sequencing solutions. The company's innovative technology and strategic partnerships position it well in the competitive biotech market.
At a glance
- Founded
- 2017
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning Element Biosciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Venrock
Foresite Capital
Fidelity Investments- JSJSCapital
Alexandria Venture Investments
RA Capital Management
Series B and later8 investors entered at this stage
Morgan Stanley
Meritech Capital
T. Rowe Price
Janus Henderson Investors- JMJS Capital Management
Logos Capital
Wellington Management
Samsung Electronics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Element Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Element Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.